Supplier of Fluoromethyl Ketones (FMK), Difluorophenoxymethylketone (Q-VD-OPH), Caspase/
Apoptosis Detection Kits, Calpain Inhibitors, Cathepsin Inhibitors, Antiviral Peptide inhibitor
(Picornavirus 2A Proteinases), Peptide Aldehyde (CHO), Caspase / Apoptosis Inhibitors and
Substrates, Diazomethylketone Inhibitors, AMC/ AFC/PNA/ Cresyl voilet/ Thiobenzyl Substrates (SBzl),
wide variety of peptides for both research and bulk pharmeceutical trials. Active Pharmaceutical
Ingredients, Custom Synthesis of Peptide and Organic molecules.
Q-VD-OPH,Z-VD-OPH, Boc-D-OPH, Z-DEVD-OPH, Z-VAD(OMe)-FMK, Z-VAD-FMK( non methylated)
Boc-D-FMK,Z-DEVD-FMK, Z-IETD-FMK, Z-LEHD-FMK, Z-VEID-FMK, Z-AEVD-FMK, Z-VDVAD-FMK,
Z-LEVD-FMK,Z-ATAD-FMK, Biotin-VAD-FMK, Biotin-DEVD-FMK, Z-FA-FMK, Biotin-FA-FMK, Z-FF-FMK,
Z-LLY-FMK, Z-VAM-FMK, FITC-VAD-FMK, FAM-VAD-FMK, FAM-DEVD-FMK, SR-VAD-FMK, SR-DEVD-FMK,
CASPASE / APOPTOSIS INHIBITORS AND DETECTION KITS CATHEPSIN, CALPAIN INHIBITORS, PEPTIDE
ALDEHYDE INHIBITORS, FLUOROGENIC (AMC, AFC), GLY-PHE-DIAZOMETHYLKETONE, CHROMOGENIC
( PNA ) SUBSTRATES.
CRESYL VOILET SUBSTRATES ( A new cell permeable fluorogenic substrate) THIOBENZYL ESTER
(SBzl) SUBSTRATES
SM Biochemicals offers a wide variety of peptides including Adrenocorticotropic Hormone(ACTH),
Adrenomedullins, ADAM Substrate, Agatoxin IVa, Akt Substrate, All D Beta Amyloid, Alpha MSH,
Amylin, Amyloid, Angiotensin, APP, a great number of Beta Amyloids which have been found to offer
useful tools in Alzheimer's research. Bradykinin, Calcitonin, Casein Kinase, Cecropin B,Cecropin
P1,porcine, Corticotropin,Endothelins, Endothelin Antagonists, Exendin 3, Enzyme Inhibitors, Fibrinogen
Binding, Fibrinopeptide, Flag Peptide, Furin InhibitorII ,Galani , Galantide, Gamma Secretase Inhibitor,
Gastric Inhibitory Peptide, human / GIP, human, Gastrin, Gastrin Releasing Peptide, human / GRP,
Ghrelin, Glucagon, Growth Hormone Releasing Factor, H.I.V. -1 Protease, Hepatitis C Virus, HIV
Substrate IV, HIV Substrate IV Inhibitor I, Humanin, KISS, Leumorphin, LH-RH Free Acid,
Locustapyrokinin, MG-132/ Proteosome inhibitor, MMP Substrates and Inhibitors, MOG Protein, Motlin
Peptides, Myosin, MZ Peptides, Neuropeptide, Neurotensin, NFF2 MMP subsrates, Non A Beta
component Amyloid, Obestatin,Oxerin A and Oxerin B ( Human), Orntide, Oxyntomodulin, PACAP,
Pancreastatin, Pancreatic polypeptide, Parathyroid Hormone, PKA Inhibitor and Substrate,
Plasminogen activator substrate, Protein Kinase, PTH Peptide/Protein, PYY Peptide/Protein,
Sarafotoxin peptides, Somatostatin peptides,Syntide, TNF converting enzyme substrate, Tyrosine
specific protein kinase, Vasoactive intestinal constrictor, VIP peptides, VIP Antagonist, VIP Receptor,
Xenopsin.
We provide peptides for both research and bulk pharmeceutical trials. A staff with decades of
experience in peptide chemistry will help you with the design and synthesis of your custom peptides
and with the technical information necessary to help you optimize your research results.
Active Pharmaceutical Ingredients ( APIs and Intermediates). Pharmaceutically active peptides.
Call our number (714)993-9461 or (925)876-3111 or email at info@smbiochemicals.com
|
|
|
|
|
|
Acetyl Beta Amyloid
(25-35)
|
|
Acetyl-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-M
et-OH
|
|
|
|
|
Acetyl Beta Amyloid
(25-35)
|
|
Acetyl-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-
Leu-Met-OH
|
|
|
|
|
Acetyl-Neurotensin
(8-13)
|
|
Acetyl-Arg-Arg-Pro-Tyr-Ile-Leu-OH
|
|
|
|
|
Acetyl-Neurotensin
(8-13)
|
|
Acetyl-Arg-Arg-Pro-Tyr-Ile-Leu-OH
|
|
|
|
|
|
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pr
o-Val-Gly-Lys-Lys-Arg-OH
|
|
|
|
|
|
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly
-Lys-Pro-Val-Gly-Lys-Lys-Arg-OH
|
|
|
|
|
|
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pr
o-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pr
o-OH
|
|
|
|
|
|
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys
-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val
-Tyr-Pro-OH
|
|
|
|
|
|
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pr
o-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pr
o-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-
Pro-Leu-Glu-Phe-OH
|
|
|
|
|
ACTH (7-38), human /
Corticotropin Inhibiting
Peptide (7-38), human
/ CIP
|
|
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Ar
g-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-
Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-OH
|
|
|
|
|
ACTH (7-38), human /
Corticotropin Inhibiting
Peptide (7-38), human
/ CIP
|
|
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Ar
g-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-
Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-OH
|
|
|
|
|
|
L-Glu(EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Le
u-e-Dabcyl-L-Lys-NH2
|
|
|
|
|
|
L-Glu(EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-L
eu-e-Dabcyl-L-Lys-NH2
|
|
|
|
|
Adamantaneacetyl-[DA
rg0,Hyp3,Thi5,8,DPhe
7] Bradykinin
|
|
Adamataneacetyl-D-Arg-Arg-Pro-Hyp-Gly-Thi-Se
r-D-Phe-Thi-Arg-OH
|
|
|
|
|
Adamantaneacetyl-[DA
rg0,Hyp3,Thi5,8,DPhe
7] Bradykinin
|
|
Adamataneacetyl-D-Arg-Arg-Pro-Hyp-Gly-Thi-Se
r-D-Phe-Thi-Arg-OH
|
|
|
|
|
Adrenal
Secretogranin, bovine
|
|
Phe-Pro-Lys-Pro-Ala-Gly-Ser-Gln-Asp-Lys-Pro-L
eu-His-Asn-OH
|
|
|
|
|
Adrenomedullin
(11-50), rat
|
|
Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-G
ln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-
Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Il
e-Ser-Pro-Gln-Gly-Tyr-NH2
|
|
|
|
|
Adrenomedullin
(11-50), rat
|
|
Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-G
ln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-
Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Il
e-Ser-Pro-Gln-Gly-Tyr-NH2
|
|
|
|
|
Adrenomedullin
(1-50), rat
|
|
Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Th
r-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-
Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-As
p-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-
Pro-Gln-Gly-Tyr-NH2
|
|
|
|
|
Adrenomedullin
(1-50), rat
|
|
Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Th
r-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-
Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-As
p-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-
Pro-Gln-Gly-Tyr-NH2
|
|
|
|
|
Adrenomedullin
(1-52), human
|
|
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-A
rg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Va
l-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-A
sp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Ly
s-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
|
|
|
|
|
Adrenomedullin
(1-52), human
|
|
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-A
rg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Va
l-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-A
sp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Ly
s-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
|
|
|
|
|
Adrenomedullin
(22-52), human
|
|
Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe
-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-
Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
|
|
|
|
|
Adrenomedullin
(22-52), human
|
|
Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe
-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-
Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
|
|
|
|
|
Agatoxin IVa ( SS Cys
4,20 / Cys 12,25 / Cys
19,36 / Cys 27,34 )
|
|
Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cy
s-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-
Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu
-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-L
eu-Ala-OH
|
|
|
|
|
Agatoxin IVa ( SS Cys
4,20 / Cys 12,25 / Cys
19,36 / Cys 27,34 )
|
|
Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cy
s-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-
Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu
-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-L
eu-Ala-OH
|
|
|
|
|
|
Arg-Pro-Arg-Ala-Ala-Thr-Phe-NH2
|
|
|
|
|
|
Arg-Pro-Arg-Ala-Ala-Thr-Phe-NH2
|
|
|
|
SM640-10
|
All D Beta Amyloid
(1-40), human
|
D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-
D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gl
n-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu
-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-
D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val
-D-Val-OH
|
|
|
SM640-10
|
All D Beta Amyloid
(1-40), human
|
D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-
D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gl
n-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu
-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-
D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val
-D-Val-OH
|
|
|
SM781-20
|
Allatostatin B2,
cockroach
|
Ala-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro
-Val-Tyr-Asn-Phe-Gly-Leu-NH2
|
|
|
SM151-25
|
Alpha Atrial Natriuretic
Polypeptide (1-28),
human / ANP (1-28),
human
|
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-M
et-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-
Asn-Ser-Phe-Arg-Tyr-OH
|
|
|
SM151-25
|
Alpha Atrial Natriuretic
Polypeptide (1-28),
human / ANP (1-28),
human
|
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-M
et-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-
Asn-Ser-Phe-Arg-Tyr-OH
|
|
|
SM570-42
|
Alpha MSH [D-Phe7]
|
Acetyl-Ser-Tyr-Ser-Met-Glu-His-D-Phe-Arg-Trp-G
ly-Lys-Pro-Val-NH2
|
|
|
SM570-42
|
Alpha MSH [D-Phe7]
|
Acetyl-Ser-Tyr-Ser-Met-Glu-His-D-Phe
-Arg-Trp-Gly-Lys-Pro-Val-NH2
|
|
|
SM570-43
|
Alpha MSH
[Nle4,D-Phe7]
|
Acetyl-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-G
ly-Lys-Pro-Val-NH2
|
|
|
SM570-43
|
Alpha MSH
[Nle4,D-Phe7]
|
Acetyl-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-G
ly-Lys-Pro-Val-NH2
|
|
|
SM571-49
|
Alpha MSH, Ac-NLe4
c[Asp5,DNal7,Lys10](4
-10) amide
|
Acetyl-Nle-Asp-His-D-Napthyl-Ala-Arg-Trp-Lys-N
H2
|
|
|
SM571-49
|
Alpha MSH, Ac-NLe4
c[Asp5,DNal7,Lys10](4
-10) amide
|
Acetyl-Nle-Asp-His-D-Napthyl-Ala-Arg-Trp-Lys-N
H2
|
|
|
SM571-56
|
Alpha MSH, Ac-Nle4
c[Asp5,D-Phe7,Lys10]
(4-10) amide
|
Acetyl-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2
|
|
|
SM571-56
|
Alpha MSH, Ac-Nle4
c[Asp5,D-Phe7,Lys10]
(4-10) amide
|
Acetyl-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2
|
|
|
SM641-50
|
Amylin (1-37) NH2,
human / Islet Amyloid
Polypeptide (IAPP),
cyclic
|
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-L
eu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-P
he-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-
Asn-Thr-Tyr-NH2
|
|
|
SM641-50
|
Amylin (1-37) NH2,
human / Islet Amyloid
Polypeptide (IAPP),
cyclic
|
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-L
eu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-P
he-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-
Asn-Thr-Tyr-NH2
|
|
|
|
